Importantly, our model recapitulates this pattern, with CD4+ FOXP3+ Tregs enriched in the core region, where viable and transcriptionally altered CLL B cells are concentrated. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.